Aphios® Corporation, a green biotechnology company is developing enabling technology platforms designed to improve drug discovery and manufacturing, nanotechnology drug delivery and pathogenic drug safety. Using these enabling technology platforms, Aphios® and its collaborators are developing enhanced therapeutics for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and Central Nervous System (CNS) disorders.

• Enabling Technology Platforms

• Enhanced Therapeutic Products

• Frost & Sullivan 2009 Best Practices Award for Nanodrug Therapeutic Systems

• Pharma & Biotech Cleantech 2007 Venture & Partnering Award

For further information on our enabling technology platforms and enhanced therapeutic products, kindly contact us.

Site updated on April 19, 2012

Home l Company | Product Pipeline | Patents | Press Releases | Purchase Products | Contact Aphios